Glucagon-Like Peptide-1 Receptor Agonist Therapy and Neurocognitive Outcomes in Medically Managed Idiopathic Intracranial Hypertension: A Propensity Score-Matched Cohort Study
{{output}}
Background: GLP-1 receptor agonists (GLP-1RAs) have been shown to reduce invasive interventions and improve symptom control in idiopathic intracranial hypertension (IIH). However, their impact on neurocognitive outcomes remains u... ...
